Chemtrade Logistics Income Fund press release ( CGIFF ): Q4 Revenue of $502M. Adjusted EBITDA of $98.2 million a decrease of $10.4 million or 9.6% year-over-year. Excluding the impact of foreign exchange, Adjusted EBITDA for the fourth quarter was $10.0 million lower than 2024 due to lower margins for most key products, other than merchant acid. Net earnings of $38.3 million, an increase of $28.0 ...
Chemtrade Logistics Income Fund press release ( CGIFF ): Q4 Revenue of $502M. Adjusted EBITDA of $98.2 million a decrease of $10.4 million or 9.6% year-over-year. Excluding the impact of foreign exchange, Adjusted EBITDA for the fourth quarter was $10.0 million lower than 2024 due to lower margins for most key products, other than merchant acid. Net earnings of $38.3 million, an increase of $28.0 million year-over-year primarily due to favourable unrealized foreign exchange gains and lower finance costs in 2025 and an impairment loss in 2024, partially offset by lower Adjusted EBITDA. Cash flows from operating activities of $85.5 million, an increase of $1.6 million or 1.9% year-over-year, mainly due to a decrease in working capital and lower income taxes paid partially offset by lower Adjusted EBITDA. More on Chemtrade Logistics Income Fund Seeking Alpha’s Quant Rating on Chemtrade Logistics Income Fund Historical earnings data for Chemtrade Logistics Income Fund Dividend scorecard for Chemtrade Logistics Income Fund Financial information for Chemtrade Logistics Income Fund
Vir Biotechnology ( VIR ) priced its public offering of ~17.65M shares of common stock at $8.50 per share. Gross proceeds are expected to be about $150M. The underwriters have a 30-day option to buy up to 2.65M additional shares. The offering is expected to close on February 27, 2026. The stock price dropped 2.9% on Wednesday during after-market hours of trading. More on Vir Biotechnology Vir Biot...
Vir Biotechnology ( VIR ) priced its public offering of ~17.65M shares of common stock at $8.50 per share. Gross proceeds are expected to be about $150M. The underwriters have a 30-day option to buy up to 2.65M additional shares. The offering is expected to close on February 27, 2026. The stock price dropped 2.9% on Wednesday during after-market hours of trading. More on Vir Biotechnology Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript Vir Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation Vir Biotechnology launches $200M public stock offering Vir Biotechnology outlines $1.7B Astellas collaboration and anticipates cash runway into Q2 2028 as VIR-5500 advances
Hycroft Mining's major new mineral resource estimate suggests the company could be sitting on about $50 billion in gold and silver, but can it follow through?
Hycroft Mining's major new mineral resource estimate suggests the company could be sitting on about $50 billion in gold and silver, but can it follow through?
In this article STLA Follow your favorite stocks CREATE FREE ACCOUNT Antonio Filosa attends the presentation of the new Fiat 500 Hybrid at the Stellantis FIAT Mirafiori plant in Turin, Italy, on November 25, 2025. Nurphoto | Nurphoto | Getty Images Auto giant Stellantis on Thursday reported its first-ever annual loss after saying it had over-estimated the pace of the energy transition. The multina...
In this article STLA Follow your favorite stocks CREATE FREE ACCOUNT Antonio Filosa attends the presentation of the new Fiat 500 Hybrid at the Stellantis FIAT Mirafiori plant in Turin, Italy, on November 25, 2025. Nurphoto | Nurphoto | Getty Images Auto giant Stellantis on Thursday reported its first-ever annual loss after saying it had over-estimated the pace of the energy transition. The multinational conglomerate, which owns household names including Jeep, Dodge, Fiat, Chrysler and Peugeot, posted a full-year 2025 net loss of 22.3 billion euros ($26.3 billion), compared to full-year profit of 5.5 billion euros a year ago. The net loss was impacted by 25.4 billion euros in write-downs from last year, Stellantis said, citing a major strategic shift. Stellantis said it had suspended its dividend for 2026, as it had previously flagged, and issued up to 5 billion euros of hybrid bonds. It also reiterated its 2026 forecasts, including a mid-single-digit percentage increase in net revenues and a low-single-digit adjusted operating margin. "Our 2025 full year results reflect the cost of over-estimating the pace of the energy transition and of the need to reset our business around our customers' freedom to choose from the full range of electric, hybrid and internal combustion technologies," Stellantis CEO Antonio Filosa said in a statement. "In 2026 our focus will be on continuing to close the execution gaps of the past, adding further momentum to our return to profitable growth," he added. This is breaking news. Please refresh for updates.
Luis Alvarez/DigitalVision via Getty Images Back in September 2025, I wrote an article on LifeMD ( LFMD ) and assigned my first ever Strong Buy rating. I saw LifeMD as an underappreciated telehealth company with a similar business model to Hims & Hers Health ( HIMS ) but at a much cheaper price. At the time of writing that article, LifeMD had already seen a huge price correction, and in my eyes, i...
Luis Alvarez/DigitalVision via Getty Images Back in September 2025, I wrote an article on LifeMD ( LFMD ) and assigned my first ever Strong Buy rating. I saw LifeMD as an underappreciated telehealth company with a similar business model to Hims & Hers Health ( HIMS ) but at a much cheaper price. At the time of writing that article, LifeMD had already seen a huge price correction, and in my eyes, it was cheap after having come back down to earth from optimistic assumptions (the stock peaked at $15 in the earlier part of 2025). But since my article, LFMD has fallen through the floor and is down a whopping 55%. HIMS has had an even worse time, falling 70% since the same date. The market seems to be seeing some serious risks with this business model. It could be that these stocks are being swept up in a wider software selloff amid uncertainty around AI and software moats. There's also a rapidly changing story with GLP-1s, and Hims in particular is in hot water with its compounded solutions for proprietary weight loss drugs, facing lawsuits from Novo Nordisk . Growth could also just be stalling as the addressable market for telehealth is running out. A lot of the risks with LifeMD were present the first time around, and I don't think the story has changed much for these companies. But now the opportunity has completely shifted, as LifeMD is priced with a lot of pessimism baked in. In this article we'll review LifeMD's updates and carefully scrutinize my previous bull case to see where it holds up and what red flags may have emerged. We'll also take a look at LifeMD's preferred shares, which are yielding just under 10% at the time of writing. Ultimately, I still think LifeMD is a tremendously undervalued stock, and there is a lot of upside to be unlocked if management executes at any sort of decent level. The difference from last year is that the crashing stock price has lowered the bar for what this company needs to achieve before a rerating will be in order. Let's dive ...
(RTTNews) - Bouygues (EN.PA) reported fiscal 2025 net profit attributable to the Group including exceptional income tax surcharge for large companies in France of 1.14 billion euros compared to 1.06 billion euros, prior year. Net profit attributable to the Group excluding excepti
(RTTNews) - Bouygues (EN.PA) reported fiscal 2025 net profit attributable to the Group including exceptional income tax surcharge for large companies in France of 1.14 billion euros compared to 1.06 billion euros, prior year. Net profit attributable to the Group excluding excepti
MF3d/iStock via Getty Images Buying low and selling high sounds simple. But in practice, it’s one of the most consistently failed “skills” in investing. Prices fall, sentiment deteriorates, and what looked attractive at higher levels suddenly feels uninvestable. The recent crash over the last few weeks and months in Bitcoin's prices is a good example of this dynamic. Nothing has fundamentally brok...
MF3d/iStock via Getty Images Buying low and selling high sounds simple. But in practice, it’s one of the most consistently failed “skills” in investing. Prices fall, sentiment deteriorates, and what looked attractive at higher levels suddenly feels uninvestable. The recent crash over the last few weeks and months in Bitcoin's prices is a good example of this dynamic. Nothing has fundamentally broken in Bitcoin over the last few months, and yet, its price in USD has fallen dramatically since its all-time high in October. Data by YCharts This should be a prime opportunity to buy more of the NEOS Bitcoin High Income ETF ( BTCI ). An asset such as Bitcoin does not have clearly definable intrinsic value, as the ultimate goals of cryptocurrency in general are ideological in nature. I am generally bullish on cryptocurrency and Bitcoin, but determining price targets for Bitcoin is largely speculation. That's why BTCI is so interesting and attractive. The fund allows you to participate in some of the speculation behind Bitcoin while monetizing what's real, which, in the case of Bitcoin, is its volatility. I maintain a Buy rating on BTCI and would continue adding to a position unless Bitcoin fundamentals break. Nothing Has Fundamentally Changed For Bitcoin The drops in Bitcoin may look scary, especially to those who haven't traded Bitcoin in its early days. Institutions and investors who buy ETFs aren't used to assets as large as Bitcoin losing half its value in a matter of months, after all. However, it's not so scary when you look at Bitcoin's history of crashes . Bitcoin's first major crash was in 2011. After rising to around $30, Bitcoin fell over 90% to roughly $2. The crash was largely attributed to a hack in the prominent exchange at the time, Mt. Gox, where a significant amount of bitcoins were stolen from various wallets. This problem with the Mt. Gox exchange would lead to another crash between 2013 and 2015 where the collapse of the exchange would lead to a prolong...
syahrir maulana/iStock via Getty Images Market and portfolio review US equity markets posted positive returns once again in Q4 with the Russell 2000 Index returning 2.19%, roughly even with the Russell 1000 Index return of 2.41% for the quarter. Interestingly, the smallest end of the market cap range fared even better during the quarter, with the Russell Microcap Index increasing 6.25%. From a sec...
syahrir maulana/iStock via Getty Images Market and portfolio review US equity markets posted positive returns once again in Q4 with the Russell 2000 Index returning 2.19%, roughly even with the Russell 1000 Index return of 2.41% for the quarter. Interestingly, the smallest end of the market cap range fared even better during the quarter, with the Russell Microcap Index increasing 6.25%. From a sector perspective, health care (+18.6%) was by far the best-performing sector in the Russell 2000 Index, propelled by strength in both biotech and pharmaceuticals. In a distant second, materials were +5.0% as metals and mining-related stocks continued to perform well. Consumer staples (-4.6%), information technology (-4.5%) and consumer discretionary (-4.1%) were the worst-performing sectors. Heightened uncertainty, increased headline and geopolitical risk, and a corresponding backdrop of volatility seemed to be the name of the game in 2025, and Q4 continued to fit that pattern. The momentum-driven, low-quality rally that took off in earnest in early August continued for most of the quarter, but the euphoric sentiment hit the brakes a bit in December. This appeared to be driven by a combination of greater investor scrutiny around AI beneficiaries, increased discussion of market bubbles, and mixed signals around labor and the consumer. Despite posting a slightly negative return in December, the Russell 2000 Index finished the year up 12.81%. Several factors continue to support the case for potential ongoing strength heading into 2026, including a solid US macro backdrop, lower interest rates and increased investor optimism around the near-term impact of the One, Big, Beautiful Bill Act. While we expect news flow and volatility are likely to remain elevated, we continue to focus on owning resilient businesses that are built with the ability to take advantage of as well as endure through ongoing uncertainty. We continue to see opportunity among businesses with exposure to indust...
NoDerog/iStock Unreleased via Getty Images Shares of Marriott Vacations Worldwide ( VAC ) have been a poor performer over the past year, losing about a third of their value. The timeshare, or “vacation ownership interest” (“VOI”), company has struggled with weak sales as cautious consumers have been reluctant to make new VOI purchases. I last covered shares in September , when I made the poor deci...
NoDerog/iStock Unreleased via Getty Images Shares of Marriott Vacations Worldwide ( VAC ) have been a poor performer over the past year, losing about a third of their value. The timeshare, or “vacation ownership interest” (“VOI”), company has struggled with weak sales as cautious consumers have been reluctant to make new VOI purchases. I last covered shares in September , when I made the poor decision to upgrade the stock to a “buy” after a period of underperformance. Since then, the stock has lost a further 18% given weak sales and management turnover, though VAC rallied over 8% on Q4 results that were not as bad as feared. With updated financials, now is a good time to revisit VAC to determine if shares can turn around or if they should be avoided. Seeking Alpha New Leadership Refocuses the Business In the company’s fourth quarter , Marriott Vacation earned $1.86, which was $0.15 ahead of expectations as revenue fell modestly to $1.3 billion. VAC generated $186 million of adjusted EBITDA at the high-end of its prior guidance. I would note these results exclude certain one-time items. During the quarter, the company took a $546 million impairment. There were three components of this write-down. It took a $175 million loss on projects it no longer expects to build, given relatively weak demand, a $160 million write-down on properties it is in the process of selling, and a $184 reduction in goodwill. These impairments come after management change. Shortly after reporting weak Q3 results, the company announced the departure of its CEO and appointment of an interim CEO from its board, speaking to a messy transition. In February , VAC announced Matthew Avril would remain in place as the permanent CEO while retaining his seat on the board. The decision to abandon some projects and write-down assets reflects new management “clearing the deck” to refocus the business on higher-performing locations and curtail excessive growth given the fairly lackluster demand environment....
(RTTNews) - Adtran Holdings, Inc. (ADTN), a Huntsville, Alabama-based technology company, on Thursday reported its net loss narrowed in the fourth quarter due to higher revenue compared with the previous year.
(RTTNews) - Adtran Holdings, Inc. (ADTN), a Huntsville, Alabama-based technology company, on Thursday reported its net loss narrowed in the fourth quarter due to higher revenue compared with the previous year.
India heads into 2026 with major trade deals and returning inflows, but markets aren’t exactly celebrating. We asked four experts where to invest ₹10 lakh right now. Here’s what they said. (Source: Bloomberg)
India heads into 2026 with major trade deals and returning inflows, but markets aren’t exactly celebrating. We asked four experts where to invest ₹10 lakh right now. Here’s what they said. (Source: Bloomberg)
German Chancellor Friedrich Merz lands in Beijing on Feb. 25. Photo: VCG German Chancellor Friedrich Merz called for transparent communication channels with Beijing as he arrived for his first official visit to China, attempting to balance deep economic ties with growing concerns over trade imbalances. “Berlin and Beijing are nearly 7,500 kilometers apart. For many years, we have been happy to bri...
German Chancellor Friedrich Merz lands in Beijing on Feb. 25. Photo: VCG German Chancellor Friedrich Merz called for transparent communication channels with Beijing as he arrived for his first official visit to China, attempting to balance deep economic ties with growing concerns over trade imbalances. “Berlin and Beijing are nearly 7,500 kilometers apart. For many years, we have been happy to bridge this distance. For me, it is very important to maintain and deepen our diplomatic and economic relations. To achieve this goal, we need open channels of dialogue,” Merz wrote in a post on the social media platform X in Chinese Wednesday.